Human recombinant granulocyte colony-stimulating factor for the treatment of autoimmune neutropenia

Acta Haematol. 1991;86(2):95-8. doi: 10.1159/000204811.

Abstract

We have recently treated a case of autoimmune neutropenia in a 57-year-old male. Because neutropenia persisted despite the administration of prednisolone for 30 days, daily subcutaneous injection of human recombinant granulocyte colony-stimulating factor (rhG-CSF) at a dosage of 100 micrograms was started. Neutrophil count increased gradually and reached a plateau of 5,000/microliters by day 25 after administration of rhG-CSF. This observation suggests that rhG-CSF is effective for the treatment of autoimmune neutropenia.

Publication types

  • Case Reports

MeSH terms

  • Autoimmune Diseases / drug therapy*
  • Bone Marrow / pathology
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Neutropenia / drug therapy
  • Neutropenia / immunology*
  • Neutropenia / pathology
  • Prednisolone / therapeutic use
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Prednisolone